This page in English
Laddar profil information


Physical activity, sleep and risk of respiratory infections: A Swedish cohort study
Ghilotti F, Pesonen As, Raposo Se, Winell H, Nyrén O, Trolle Lagerros Y, et al
PloS one 2018;13(1):e0190270-

Intake of vitamin C, vitamin E, selenium, zinc and polyunsaturated fatty acids and upper respiratory tract infection-a prospective cohort study
Raposo Se, Fondell E, Ström P, Bälter O, Bonn Se, Nyrén O, et al
European journal of clinical nutrition 2017;71(4):450-457

More chinks in the armor of cancer: potential for new therapies
Hainaut P, Plymoth A
Current opinion in oncology 2017;29(1):33-34

Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
Duarte-salles T, Misra S, Stepien M, Plymoth A, Muller D, Overvad K, et al
Cancer prevention research (Philadelphia, Pa.) 2016;9(9):758-65

Editorial: from cancer genotypes to phenotypes: a never-ending complexity
Hainaut P, Plymoth A
Current opinion in oncology 2016;28(1):50-1

Letter to the editor
Linde A, Plymoth A
Clinical epidemiology 2016;8():295-6

Prevalence of gastro-esophageal reflux disease and its risk factors in a community-based population in southern India
Wang Hy, Leena Kb, Plymoth A, Hergens Mp, Yin L, Shenoy Kt, et al
BMC gastroenterology 2016;16():36-

Osteopontin and latent-TGF beta binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma
Da Costa An, Plymoth A, Santos-silva D, Ortiz-cuaran S, Camey S, Guilloreau P, et al

Self-sampling for analysis of respiratory viruses in a large-scale epidemiological study in Sweden
Plymoth A, Rotzen-ostlund M, Zweygberg-wirgart B, Sundin Cg, Ploner A, Nyren O, et al
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2015;20(11):-

The genetic-metabolic duality of cancer
Hainaut P, Plymoth A
Current opinion in oncology 2014;26(1):62-3

Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand
Ortiz-cuaran S, Villar S, Gouas D, Ferro G, Plymoth A, Khuhaprema T, et al
CANCER LETTERS 2013;331(1):46-51

Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy
Hainaut P, Plymoth A
Current opinion in oncology 2013;25(1):50-1

Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis
Villar S, Ortiz-cuaran S, Abedi-ardekani B, Gouas D, Da Costa An, Plymoth A, et al
PLOS ONE 2012;7(6):e37707-

Cancer as a metabolic disease
Hainaut P, Plymoth A

Identification of osteopontin as a novel marker for early hepatocellular carcinoma
Shang Sf, Plymoth A, Ge Sk, Feng Zd, Rosen Hr, Sangrajrang S, et al
HEPATOLOGY 2012;55(2):483-90

Biomarkers in cancer research and treatment: promises and challenges
Hainaut P, Plymoth A

Proteomics beyond proteomics: toward clinical applications
Plymoth A, Hainaut P

Seasonal Variation in TP53 R249S-Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection
Villar S, Le Roux-goglin E, Gouas Da, Plymoth A, Ferro G, Boniol M, et al

Control of hepatocellular carcinoma through Hepatitis B vaccination in areas of high endemicity: Perspectives for global liver cancer prevention
Plymoth A, Viviani S, Hainaut P
CANCER LETTERS 2009;286(1):15-21

Editorial foreword special issue "Hepatocellular Carcinoma - A Worldwide Translational Approach"
Plymoth A, Chemin I, Boffetta P, Hainaut P
CANCER LETTERS 2009;286(1):3-4

Recent advances in p53 research: an interdisciplinary perspective
Olivier M, Petitjean A, Marcel V, Petre A, Mounawar M, Plymoth A, et al
CANCER GENE THERAPY 2009;16(1):1-12

20 Years into the Gambia Hepatitis Intervention Study: Assessment of Initial Hypotheses and Prospects for Evaluation of Protective Effectiveness Against Liver Cancer
Gambia Hepatitis Intervention Stud, Viviani S, Carrieri P, Bah E, Hall Aj, Kirk Gd, et al

Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers
Plymoth A, Lofdahl Cg, Ekberg-jansson A, Dahlback M, Broberg P, Foster M, et al
CLINICAL CHEMISTRY 2007;53(4):636-44

Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never-smokers by micro-scale liquid chromatography and mass spectrometry
Plymoth A, Yang Zp, Lofdahl Cg, Ekberg-jansson A, Dahlback M, Fehniger Te, et al
CLINICAL CHEMISTRY 2006;52(4):671-9

Analysis and understanding of high-dimensionality data by means of multivariate data analysis
Norden B, Broberg P, Lindberg C, Plymoth A
CHEMISTRY & BIODIVERSITY 2005;2(11):1487-94

Selection of protein expression signatures by interfacing pathophysiology and proteomics technology in smokers and never-smokers
Plymoth A, Lofdahl C, Ekberg-jansson A, Dahlback M, Broberg P, Fehniger Te, et al

Human bronchoalveolar lavage: Biofluid analysis with special emphasis on sample preparation
Plymoth A, Lofdahl Cg, Ekberg-jansson A, Dahlback M, Lindberg H, Fehniger Te, et al
PROTEOMICS 2003;3(6):962-72

Identification of galectin ligands in human serum and blood cells
Cederfur C, Qian Yn, Lexander H, Hedlund M, Plymoth A, Ling M, et al
FASEB JOURNAL 2003;17(4):A161-A161

Visa alla publikationer


View map

Nobels väg 12A